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Metabotropic glutamate receptors (mGluRs) regulate intracellular signal pathways that
control several physiological tasks, including neuronal excitability, learning, and memory.
This is achieved by the formation of synaptic signal complexes, in which mGluRs
assemble with functionally related proteins such as enzymes, scaffolds, and cytoskeletal
anchor proteins. Thus, mGluR associated proteins actively participate in the regulation
of glutamatergic neurotransmission. Importantly, dysfunction of mGluRs and interacting
proteins may lead to impaired signal transduction and finally result in neurological
disorders, e.g., night blindness, addiction, epilepsy, schizophrenia, autism spectrum
disorders and Parkinson’s disease. In contrast to solved crystal structures of extracellular
N-terminal domains of some mGluR types, only a few studies analyzed the conformation
of intracellular receptor domains. Intracellular C-termini of most mGluR types are subject
to alternative splicing and can be further modified by phosphorylation and SUMOylation.
In this way, diverse interaction sites for intracellular proteins that bind to and regulate the
glutamate receptors are generated. Indeed, most of the known mGluR binding partners
interact with the receptors’ C-terminal domains.Within the last years, different laboratories
analyzed the structure of these domains and described the geometry of the contact
surface between mGluR C-termini and interacting proteins. Here, I will review recent
progress in the structure characterization of mGluR C-termini and provide an up-to-date
summary of the geometry of these domains in contact with binding partners.
Keywords: binding surface, metabotropic glutamate receptor, G-protein coupled receptor, mGluR, protein-protein
interaction, signaling complex, short linear motif, structure
INTRODUCTION
The coordinated neuronal activity in the central nervous system
(CNS) is largely guided by receptors for various neurotrans-
mitters that are expressed at synaptic specializations. A correct
localization and regulation of these neurotransmitter receptors
is crucial for proper function of the neuronal network. This
is mainly accomplished by proteins that interact with cytosolic
receptor domains, thereby regulating localization, turnover and
ligand affinity of these proteins (see e.g., Bard and Groc, 2011;
Maurice et al., 2011). Thus, neurotransmitter receptors are central
components of synaptically localized signal complexes, in which
functionally related proteins, such as transmembrane proteins,
enzymes, scaffolds, and anchor proteins assemble to secure a
dynamic regulation of synaptic neurotransmission and neuronal
Abbreviations: Å, angstrom; AC, adenylate cyclase; cAMP, cyclic adenosine
monophosphate; CD, circular dichroism; CNS, central nervous system; CT,
C-terminus; ELM, eukaryotic linear motif; EVH1, enabled/VASP homology type 1;
HSQC, heteronuclear single quantum coherence; IP3, inositol-1,4,5-trisphosphate;
mGluR, metabotropic glutamate receptor; NMDA, N-methyl-D-aspartate; NMR,
nuclear magnetic resonance; ns, nano second; PC2, polycomb protein; PDZ,
postsynaptic density 95/discs-large/zona occludens 1; PIAS, protein inhibitor of
activated STAT; PICK, protein interacting with C-kinase; PKA, protein kinase A;
PKC, protein kinase C; PLC, phospholipase C; PP1, protein phosphatase 1; RanBP2,
Ran binding protein 2; RanGAP1, Ran GTPase activating protein 1; SLiM, short
linear motif; SUMO, small ubiquitin-like modifier; S-SCAM, synaptic scaffolding
molecule.
excitability, both in space and time. Dysfunction of these signal
complexes disturbs this coordinated interplay and can ultimately
result in neurological diseases such as night blindness, addiction,
depression, anxiety, epilepsy, schizophrenia, autism spectrum dis-
orders, and Parkinson’s disease (Szumlinski et al., 2006; Nicoletti
et al., 2011).
METABOTROPIC GLUTAMATE RECEPTORS
Glutamate is the most important excitatory neurotransmitter
in the CNS and binds to ionotropic (ion channel associated)
and metabotropic (G-protein coupled) glutamate receptors
(mGluRs). About 20 years ago, the first glutamate-gated
G-protein coupled receptor (mGluR1) was discovered (Houamed
et al., 1991; Masu et al., 1991). Today, eight mGluR types
are described that are subdivided in three groups: Group I—
mGluR1 and mGluR5, group II—mGluR2 and mGluR3, group
III—mGluR4, mGluR6, mGluR7 and mGluR8 (Ferraguti and
Shigemoto, 2006). Generally, group I receptors are expressed at
the postsynapse, members of group II were found both pre-
and postsynaptically and group III mGluR types show a clear
preference for the presynaptic terminal. While ionotropic gluta-
mate receptors are mostly expressed opposite to the active zone
of neurotransmitter release, group I mGluR types were found
perisynaptically, regulating the activity of their ionotropic coun-
terparts (Baude et al., 1993; Nusser et al., 1994; Lujan et al., 1997).
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Interestingly, mGluR5 is also expressed on intracellular mem-
branes of the endoplasmic reticulum and nucleus, where it is
involved in the regulation of gene expression (Jong et al., 2009;
Kumar et al., 2011).
Except mGluR6, group III mGluR types represent presynaptic
auto-receptors that function as glutamate sensors for glutamater-
gic neurons and inhibit the release of this neurotransmitter upon
activation. Interestingly, the localization of group III mGluR
types in synapses of presynaptic terminal systems depends on
the nature of the postsynaptic neuron contacted. Originally, an
asymmetric distribution of mGluR7 was observed in presynap-
tic terminals of hippocampal pyramidal cells and bipolar cells of
the mammalian retina (Brandstätter et al., 1996; Shigemoto et al.,
1996). Later, a comparable receptor segregation was also reported
for mGluR4 and mGluR8 in the hippocampus (Shigemoto et al.,
1997). The authors suggest the existence of a retrograde signal
that regulates the amount of group III mGluR types in the presy-
napse. In contrast to the presynaptic localization of mGluR4,
mGluR7, and mGluR8, mGluR6 is exclusively expressed at post-
synaptic dendritic specializations of “ON bipolar cells” (bipolar
cells that respond with depolarization to light) in the retina and
transmits the “light on” signal in vision (Masu et al., 1995; Vardi
et al., 2000). A more detailed overview of the cellular and subcel-
lular distribution of mGluR types can be found, e.g., in (Ferraguti
and Shigemoto, 2006).
Today, more than 800 G-protein coupled receptor are known
in humans, the majority of them functioning as sensors for envi-
ronmental stimuli, such as olfaction, taste, and vision (Harmar
et al., 2009). Being typical members of the G-protein coupled
receptor class C, mGluRs contain seven transmembrane helices
for membrane anchoring and rather large N- and C-terminal
domains (Figure 1A). While the extracellular N-terminus forms
the ligand-binding domain and mediates receptor dimerization,
intracellular domains provide several interaction motifs for bind-
ing partners (Figure 1B). Intracellular C-termini of most mGluR
types are subject to alternative splicing and post-translational
modification, thereby increasing amount and diversity of avail-
able interaction sites for regulatory proteins.
BINDING PARTNERS OF METABOTROPIC GLUTAMATE
RECEPTORS
MGluRs contact heterotrimeric G-proteins to regulate intracel-
lular second messenger cascades. Group I mGluRs preferen-
tially activate phospholipase C (PLC) and thereby stimulate the
production of the second messenger molecules inositol-1,4,5-
trisphosphate (IP3) and diacylglycerol. In contrast, mGluR types
belonging to group II and III primarily reduce the concentration
of cAMP by inhibiting adenylate cyclase (AC) activity. However,
distinct coupling behavior was observed depending on the cell
type analyzed. In cerebellar neurons, a dual mode of action has
been suggested for the group III variant mGluR7a, in which the
receptor reduces or stimulates the release of glutamate from the
presynaptic terminal into the synaptic cleft by coupling to either
AC or PLC pathways (Perroy et al., 2000; Martin et al., 2010).
Besides contacting heterotrimeric G-proteins, intracellular
C-terminal domains of various mGluR types physically inter-
act with several other proteins. These mGluR interactors include
enzymes, ion channels, receptors, scaffolds, and cytoskeleton
proteins that anchor the receptors at specific subcellular sites.
MGluR interacting proteins regulate the efficacy of G-protein
coupling, as well as G-protein independent tasks including target-
ing, localization, turnover, and glutamate affinity of the receptors.
For example, G-protein coupled receptor kinase 2 (GRK2) and
β-arrestin1 interact with the C-terminal domain of mGluR1a
(Dale et al., 2001; Dhami et al., 2005). Receptor internalization is
dependent on GRK2 activity and arrestin and an involvement of
25 amino acids located in the proximal region of the mGluR1a
C-terminus has been suggested in this process (Mundell et al.,
2003). In addition, binding of GRK2 to the second intracellu-
lar loop of mGluR1a promotes a phosphorylation and arrestin
independent down-regulation of receptor mediated G-protein
signaling (Dhami et al., 2005). The authors propose that the
additional binding of GRK2 to the mGluR1a C-terminus may
regulate the efficacy of this process. Some cytosolic mGluR bind-
ing partners physically link mGluR signaling with other recep-
tor types, e.g., IP3 receptors or ionotropic glutamate receptors
of the NMDA type (Shiraishi-Yamaguchi and Furuichi, 2007).
In addition, mGluRs are directly contacted by other receptor
types, including receptors for adenosine, dopamine, and sero-
tonin (Ciruela et al., 2001; Ferre et al., 2002; Gonzalez-Maeso
et al., 2008; Cabello et al., 2009). For a comprehensive overview
of mGluR interacting proteins, mapped binding sites, and physi-
ological functions of resulting signal complexes, I refer the reader
to two recently published reviews (Enz, 2007, 2012).
Various mGluR types are associated with neurodegenerative
diseases, such as Alzheimer’s and Parkinson’s disease (Nicoletti
et al., 2011). In addition, it has been shown that an improper
assembly of mGluR associated signal complexes can cause
impaired signal transduction and ultimately may lead to neu-
rological disorders, such as congenital night blindness, anxiety,
addiction, depression, epilepsy, schizophrenia, and autism spec-
trum disorders (Szumlinski et al., 2006; Durand et al., 2007;
Bourgeron, 2009; Cao et al., 2011). Interactions between mGluR
C-termini and regulatory proteins are dynamic, which enables the
design of molecules that interfere with the assembly of mGluR
associated signal complexes. Thus, protein-protein interactions
between mGluR C-termini and regulatory proteins represent
attractive pharmaceutical targets (Enz, 2012).
STRUCTURE INVESTIGATION OF METABOTROPIC
GLUTAMATE RECEPTORS
In recent years, an increasing number of structural informa-
tion for ionotropic and metabotropic neurotransmitter receptors
has become available. For example, the three-dimensional struc-
tures of ligand-gated anion and cation channels describe detailed
mechanism of ion specificity, conductance and gating mech-
anisms (see e.g., Sobolevsky et al., 2009; Hibbs and Gouaux,
2011). Furthermore, crystal structures of adenosine, adrenalin,
dopamine, and glutamate gated G-protein coupled receptors were
reported (Kunishima et al., 2000; Muto et al., 2007; Rosenbaum
et al., 2009; Chien et al., 2010). Some of these studies analyzed in
detail the purified extracellular N-terminal domains of mGluR1,
mGluR3, and mGluR7. Besides functioning as ligand binding
domains, these N-termini form disulphide bridges which results
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FIGURE 1 | Distribution of short linear binding motifs in
mGluR C-termini. (A) The sketch shows the membrane topology
of mGluRs. Black rectangles represent the seven transmembrane
domains that anchor the receptor in the lipid bilayer (yellow/blue).
The intracellular C-terminus (bold line) contains short linear motifs
(SLiMs) that function as interaction sites for intracellular proteins
(indicated in red). (B) Amino acid sequences of mGluR7 and mGluR8
C-terminal domains are shown in the single letter code. The site for
alternative splicing generating a and b variants is indicated by a
triangle/dotted line and SLiMs are abbreviated in rectangles. Binding
sequences for Calmodulin, PP1, and SUMO proteins that are listed in
Figure 2B are highlighted in red (see main text for details). (C) Overview
of predicted and experimentally verified sequence patterns of SLiMs
shown in (B) and the description of corresponding binding domains.
Motifs were identified using pattern-based searches in the ELM databank
(Dinkel et al., 2012).
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in homo- and heteromeric mGluR dimers (Doumazane et al.,
2011). Heterodimerization was also observed between mGluR2
and the 5-HT2A serotonin receptor (Gonzalez-Maeso et al., 2008).
A molecular dynamics simulation of 40 ns suggests that the
formation of hydrogen bonds and hydrophobic microdomains
between transmembrane helixes four and five of each receptor
shape the geometry of the dimerization interface (Bruno et al.,
2009).
Noteworthy, in all above mentioned crystal structures, intra-
cellular receptor domains were deleted to allow efficient crys-
tallization, or excluded from data evaluation. Thus, structural
characteristics of mGluR intracellular domains has been analyzed
by alternative methods. In addition, for some mGluR/interactor
pairs, the geometry of the binding surface of intracellular
sequences of the glutamate receptors in contact with binding
partners was investigated by crystallography, NMR, and com-
putational techniques. In the following, I will summarize recent
progress in the structure determination of intracellular mGluR
C-termini and review available structure information of these
domains in complex with interacting proteins, as shown in
Figure 2.
STRUCTURAL ANALYSIS OF mGluR C-TERMINAL
DOMAINS
Intracellular mGluR C-termini domains are the main targets
for proteins regulating these receptors (Enz, 2007). Therefore,
elucidation of their conformation is a prerequisite for design-
ing drugs that interfere with specific protein-protein interactions
(Enz, 2012). Recently, the structure of the purified intracellular
C-termini from group III mGluR variants 6, 7a, and 8a has been
analyzed using biochemical, biophysical, and computational tech-
niques (Seebahn et al., 2011). Limited proteolysis, circular dichro-
ism (CD), as well as one- and two-dimensional nuclear magnetic
resonance (1H- and 1H-15N-NMR) spectroscopy consistently
lead to the conclusion that the unliganded mGluR C-termini do
not form secondary/tertiary structure elements that remain stable
over time. C-terminal domains of G-protein coupled receptors
are located in close proximity to the inner leaflet of the lipid
bilayer that might induce regions of ordered secondary structure.
Indeed, α-helical regions induced by lipids were observed in the
C-termini of the β-adrenergic receptor and in the cannabinoid
receptor 1 (Rasmussen et al., 2007; Ahn et al., 2009). However,
recorded 1H-15N-NHSQC spectra of the mGluR8a C-terminus
revealed no significant differences upon addition of dodecylphos-
phocholine (Seebahn et al., 2011). This observation is consistent
with the disordered nature of the mGluR7a C-terminus in the
presence of trifluoroethanol, a substance known to enhance the
formation of secondary structure elements (Isozumi et al., 2011).
Based on the available CD and NMR spectra, as well as due
to their inability to form defined crystal structures, group III
mGluR C-termini seem to be rather unstructured and may adopt
defined three-dimensional conformations only upon binding to
interacting proteins.
Indeed, unstructured/intrinsically disordered protein regions
are capable to interact with other proteins or nucleic acids by
induced fit (Figure 2; Cheng et al., 2006). Computational tech-
niques predicted the existence of several short linear motifs
(SLiMs) in mGluR C-termini (Figure 1C; Seebahn et al., 2011).
Protein interactions involving short amino acid motifs occur
more often in unstructured than structured protein regions. In
the human genome, between 15% and 40% of all protein interac-
tions are estimated to involve SliMs (Neduva and Russell, 2006).
In most cases, SLiMs do not form stable secondary structures,
but rather are highly flexible in order to adopt to the conforma-
tion defined by interacting proteins, e.g., by protein phosphatase 1
(see below). Within the C-terminal domains of group III mGluR
types, most SLiMs are present in the distal, isoform specific
regions, while some are overlapping the splice site (Figures 1B,C;
Seebahn et al., 2011). Thus, the observed alternative splicing of
most mGluR C-termini creates a large heterogeneity of interac-
tion motifs accessible for regulatory proteins.
MGluR1a, mGluR5a/b, AND mGluR7b IN CONTACT
WITH PROTEIN PHOSPHATASE 1
Several enzymes directly interact with the intracellular C-termini
of mGluR types, such as kinases, phosphatases, and proteins of
the SUMOylation machinery. In this way, the activity of mGluRs
and associated proteins is regulated by post-translational modifi-
cations, including phosphorylation and SUMOylation. G-protein
coupled receptor kinases phosphorylate intracellular mGluR
domains, which allows binding of arrestin, uncouples recep-
tor activation from G-protein signaling and stimulates recep-
tor internalization (Dhami and Ferguson, 2006). Furthermore,
PKA and PKC phosphorylate specific serine/threonine residues
in mGluR C-termini (Airas et al., 2001; Cai et al., 2001; Mao
et al., 2008). This kinase activity is antagonist by serine/threonine
protein phosphatases, such as the protein phosphatase 1 (PP1).
For proper physiological function, one PP1 catalytic subunit
assembles with a regulatory subunit. In mammals there are four
catalytic subunits known (α, β, γ1, and γ2) that interact with
several hundreds of regulatory subunits that regulate enzymatic
activity, substrate specificity and subcellular localization, thereby
creating a large diversity of PP1 holoenzymes (Shi, 2009).
The two alternatively spliced PP1 gamma subunits (PP1γ1 and
PP1γ2) interact with a linear stretch of five amino acids in the
C-termini of mGluR1a, mGluR5a/b and mGluR7b (Croci et al.,
2003; Meiselbach et al., 2006). This sequence (KSV[S/T]W; see
Figure 1B) fulfills the consensus sequence of a so-called “PP1
docking motif” that is present in several PP1 interactors, includ-
ing proteins that target the PP1 activity to ionotropic GABA
receptors (Rose et al., 2008). In the literature, various con-
sensus sequences for this docking motif are described, all of
them showing different sensitivities and specificities, e.g., (RVxF
or [HKR][ACHKMNQRSTV][V][CHKNQRST][FW]; x—any
amino acid; Meiselbach et al., 2006; Bollen et al., 2010).
Based on a solved co-crystal formed by PP1γ1 and the
interaction motif of the regulatory G-subunit that targets the
phosphatase to glycogen particles in muscle (Egloff et al.,
1997), the three-dimensional structures of the five amino
acids forming the docking motifs present in mGluR C-termini
(mGluR1a: KSVSW; mGluR5a/b and mGluR7b: KSVTW—see
Figure 1B) were modeled applying structure based computa-
tional approaches. Homology based molecular modeling and
molecular dynamics simulations showed that the backbone of the
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FIGURE 2 | Inducible structure of mGluR C-terminal sequences in
contact with interacting proteins. (A) Intrinsically disordered amino acid
sequences within mGluR C-termini (symbolized by brackets) adopt defined
confirmations upon interaction with the indicated proteins. (B) Overview of
available structure information for mGluR C-terminal sequences in complex
with binding partners. The resolution of the listed crystal structures in
angstrom is given in parenthesis. A PDB entry for the PP1γ1/GM co-crystal is
not available (−/−; Egloff et al., 1997).
five amino acids adopts an extended conformation in contact with
an acidic/hydrophobic groove on the PP1γ1 surface (Figure 3A;
Croci et al., 2003; Meiselbach et al., 2006). Within this groove,
Lys+1 and Ser+2 of the ligand form electrostatic contacts with
Asp166, Glu167, Asp242, and Glu287 of PP1γ1 (Figure 3B). In
contrast, Val+3 and Trp+5 are buried in two hydrophobic pock-
ets formed mainly by the side chains of Ile169, Leu243, Leu289,
and Cys291, or of Phe257, Met283, Cys291, and Phe293 of the
phosphatase. The side chains of Ser/Thr+4 point away from the
enzyme surface and use a water molecule to form a hydrogen-
bonding network with the backbone carbonyl oxygen of Ser+2
and Thr288 of PP1γ1 (Croci et al., 2003).
In order to gain insight in the conformational variability of
amino acids forming polar interactions, molecular dynamics sim-
ulations were applied. Within the simulation time of 1 ns, Lys+1
contacted various negatively charged amino acid side chains and
backbone carbonyl groups on the PP1γ1 surface by hydrogen
bonds and salt bridges (Figure 3B). In addition, the side chain
hydroxyl group of Ser+2 formed hydrogen bonds with the two
oxygen atoms of the carboxyl group of Asp242 in about 30% of
the simulation time (Figure 3B; Croci et al., 2003; Meiselbach
et al., 2006).
The described structural information can be translated into a
binding mechanism for PP1 docking motifs present in mGluR
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FIGURE 3 | Structure of the mGluR7b C-terminus in contact
with protein phosphatase 1 in the time course of a molecular
dynamics simulation. (A) Stick presentation of five amino acids
(KSVTW) in the mGluR7b C-terminus that contact the PP1γ1 surface
(blue) in an extended conformation. Functional groups of the mGluR7b
sequence are colored according to their atom types. Asp166, Glu167,
and Glu287 of PP1γ1 forming polar interactions with Lys+1 are shown
in brown, Asp242 of PP1γ1 contacting Ser+2 is marked in yellow.
Val+3 and Trp+5 are buried in hydrophobic pockets of the PP1γ1
surface and the side chain of Thr+4 points to the opposite direction.
(B) Enlarged views of the KSVTW ligand sequence at 0.02 ns, 0.55 ns, and
0.98 ns of molecular dynamics simulation time, as indicated. Green dotted
lines represent important electrostatic interactions formed by Lys+1 and
Ser+2 with PP1γ1.
C-terminal domains: binding is initiated by a general electrostatic
attraction between the positively charged Lys+1 and a negatively
charged surface patch of the phosphatase. Indeed, an increase
of positive charges in the ligand by inserting one, two, or three
lysine residues N-terminal of Lys+1 increased the PP1γ1 bind-
ing strength of the mGluR7b C-terminus by factors of 2, 4, and 6,
respectively (Croci et al., 2003; Meiselbach et al., 2006). After elec-
trostatic attraction, the hydrophobic interactions at position +3
and +5 of the docking motifs ensure the correct orientation of
the mGluR C-terminal domains in respect to the PP1γ1 surface.
Interestingly, Ser+2 of the mGluR1a docking motif can be phos-
phorylated by PKC (Mao et al., 2008), which might disrupt the
PP1γ1/mGluR binding surface. Indeed, when phosphorylation
of this serine was mimicked by mutation into an aspartate, the
protein interaction was completely prevented (Meiselbach et al.,
2006).
MGluR8b IN CONTACT WITH THE SUMO E2-CONJUGATING
ENZYME Ubc9
Besides protein phosphorylation, SUMOylation represents
another biological mechanism to change the surface charac-
teristic of binding partners. Although originally described for
nuclear proteins, the covalent attachment of SUMO to targets
regulates a variety of physiological processes, including transport
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of proteins, synaptic excitability and protein-protein interactions
(Wilkinson et al., 2010). Thus, as protein phosphorylation, also
SUMOylation regulates neuronal function and indeed, enzymes
of the SUMOylation machinery physically interact with neuro-
transmitter receptors and an association between SUMOylation
and neurodegeneration is discussed (Tang et al., 2005; Martin
et al., 2007; Wilkinson et al., 2010; Dütting et al., 2011).
For SUMOylation, SUMO proteins are first activated by an
E1-activating enzyme and subsequently transferred to the E2-
conjugating enzyme Ubc9 (Gareau and Lima, 2010). Ubc9 recog-
nizes consensus sequences for SUMOylation in the target that all
carry a lysine residue for covalent binding of the SUMOprotein at
position +2 (ψKx[D/E]; ψ—large hydrophobic amino acid, x—
any amino acid). This enzymatic process can be guided/facilitated
by E3-ligases, such as PC2, RanBP2, or members of the PIAS pro-
tein family. In addition to this enzymatically controlled covalent
attachment of SUMO proteins, non-covalent SUMO interaction
motifs were described (Perry et al., 2008).
SUMO E2- and E3-ligases interact with C-terminal domains
of group III mGluR types and SUMOylate the purified mGluR7a
andmGluR8aC-termini (Tang et al., 2005;Wilkinson andHenley,
2011). However, SUMOylation of the full-length mGluR7a was
undetectable (WilkinsonandHenley, 2011). Incontrast, two intra-
cellular lysine residues located in the C-terminus of the complete
mGluR8b receptor protein were SUMOylated in mammalian
cells (Dütting et al., 2011). The mGluR8b C-terminus contains
one bona-fide SUMOylation site (VKSE) that is located in the
proximal region of the mGluR8b C-terminus, which is identical
between the mGluR8a and mGluR8b isoforms (Figure 1B). In
addition, mGluR8b—but not mGluR8a—carries a second non-
canonical SUMOylation motif (VKSG) located in the isoform
specific, distal part of the C-terminus. The lysine residues present
at position +2 in both motifs were covalently linked to SUMO
proteins and this process was enhanced in the presence of the
E3-ligase PIAS1 (Dütting et al., 2011).
The three-dimensional structure of the interaction site
between the VKSE and VKSG sequences in the mGluR8b
C-terminus and the E2-conjugating enzyme Ubc9 was analyzed,
based on the solved crystal structure of RanGAP1 in com-
plex with Ubc9 (Bernier-Villamor et al., 2002). Structure-based
computational techniques predicted an extended backbone
conformation for the two mGluR8bmotifs VKSE and VKSG after
complex formation (Dütting et al., 2011). In both sequences,
Val+1 interacts with a hydrophobic pocket on the Ubc9 sur-
face, while the side chain of Ser+3 points away from the
mGluR8b/Ubc9 interface. The exchange from Glu+4 to Gly+4
in the second, non-canonical mGluR8b motif disrupts the hydro-
gen bonds formed at this position between RanGAP1 and Ubc9
in the original crystal. Estimation of the binding energy by two
independent methods suggested that the Ubc9 affinity of the
VKSG motif is reduced by 1.2–1.6 kcal/mol, which corresponds
to an 8–15-fold change (Dütting et al., 2011). Thus, compared to
the VKSE motif, the Ubc9 binding affinity of the non-canonical
VKSG motif is reduced by about one order of magnitude, being
within the range of measured binding affinities of naturally occur-
ring SUMOylation sites that show variations of up to three orders
of magnitude (Macauley et al., 2006).
MGluR7a IN CONTACT WITH CALMODULIN
Calcium ions function as second messengers and, e.g., regulate
the activity of PKC isoforms. The intracellular calcium concentra-
tion is controlled by calcium binding proteins and some of them
were shown to interact with mGluR C-termini, e.g., Calmodulin.
Interestingly, the binding of Calmodulin to group I and IIImGluR
types is regulated by both, calcium ions and PKC mediated
phosphorylation (Minakami et al., 1997; Nakajima et al., 1999;
O’Connor et al., 1999).
The three-dimensional structure of the mGluR7a C-terminus
in contact with Calmodulin was investigated using biophysi-
cal and computational techniques (Scheschonka et al., 2008).
Based on NMR spectroscopy with peptides that contain the
Calmodulin binding region of mGluR7a, the authors suggest
that amino acids 856–879 of mGluR7a, being identical between
the mGluR7a and mGluR7b isoforms (see Figure 1B), adopt
a α-helical structure that forms a 1-8-14 binding motif. This
α-helix is embedded between the globular N- and C-terminal
domains of Calmodulin in a “classical wraparound structure.”
These data are supported by homology based molecular mod-
eling using the solved crystal structure of Calmodulin in com-
plex with the smooth muscle myosin light chain kinase (PDB
entry 1QTX). Within the α-helical region of the mGluR7a
C-terminus, polar side chains of amino acids 859–861 form
electrostatic contacts, while four hydrophobic anchor residues
(Phe863, Val867, Met872, and Leu876) interact with hydrophobic
pockets of Calmodulin. The formation of an α-helical struc-
ture is further supported by the above described prediction of
SLiMs that identified an amphipathic helix (PAH2 interaction
motif) between Phe863 and Ala870 of the mGluR7a C-terminus
(Figure 1B; Seebahn et al., 2011). Furthermore, the same SLiM
was predicted in the C-termini of mGluR7b and both mGluR8
isoforms and indeed, binding of Calmodulin to these receptors
has been demonstrated (O’Connor et al., 1999; El Far et al.,
2001).
A recent study describes multiple conformations of the
mGluR7a C-terminus in complex with Calmodulin, applying
CD, and NMR measurements (Isozumi et al., 2011). Under
these experimental conditions, the Calmodulin binding region
of mGluR7a does not adopt α-helical structures that remain sta-
ble over time. Based on their data, the authors propose multiple
conformations for the mGluR7a/Calmodulin protein complex
and suggest an equilibrium between unstructured and α-helical
geometries.
MGluR1a AND mGluR5a/b IN CONTACT WITH HOMER
Homer proteins are scaffolds that interact with the group I
receptors mGluR1a and mGluR5a/b. Scaffold proteins serve as
molecular platforms that dynamically control the assembly of
functionally related molecules within the postsynaptic density
(Renner et al., 2008). Dysfunction of resulting protein complexes
may lead to neurological diseases and indeed, Homer proteins
are related to neuropsychiatric disorders, including addiction,
depression, epilepsy, and schizophrenia (Szumlinski et al., 2006;
Durand et al., 2007; Bourgeron, 2009). Besides their interaction
with group I mGluR types, Homer isoforms also bind other pro-
teins, e.g., IP3 receptors and Shank proteins (Tu et al., 1998, 1999;
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Kitano et al., 2002). Homer and Shank form a mesh-like struc-
ture in postsynaptic terminals needed for the maintenance of
dendritic spines (Hayashi et al., 2009). Therefore, it is not surpris-
ing that disassembly of this mesh-like structure by amyloid-β, or
mutations in Shank proteins are linked to CNS disorders, such as
Alzheimer’s disease or autism spectrum disorders (Durand et al.,
2007; Roselli et al., 2009).
Today, more than 20 different Homer isoforms are described
that originate form alternative splicing of three Homer genes
(Shiraishi-Yamaguchi and Furuichi, 2007). Most Homer pro-
teins are able to dimerize via a C-terminal coiled-coil region.
Furthermore, an N-terminally located Ena/VASP homology 1
(EVH1) domain binds proline rich amino acid sequences, such
as the PPxxF motif (x—any amino acid) present in the C-termini
of mGluR1a and mGluR5a/b. Thus, Homer proteins that form
dimers via their C-terminal coiled-coil regions physically link
group I mGluR types to other functionally related proteins car-
rying proline rich motifs, e.g., Shank proteins and IP3 receptors
(Tu et al., 1998, 1999). Interestingly, expression of a dominant-
negative acting Homer isoform that lacks the C-terminal dimer-
ization region (Homer 1a) is induced by neuronal activity and
interferes with the formation of mGluR/Homer associated signal
complexes (Brakeman et al., 1997; Kato et al., 1997).
The amino acid sequence TPPSPF is present in the C-termini
of mGluR1a and both mGluR5 variants, fulfills the above
described consensus sequence (PPxxF) and was co-crystallized
in complex with an EVH1 domain containing region of Homer
1a (amino acids 1–111; Beneken et al., 2000). The two con-
served proline residues within the four N-terminal amino acids
of the binding motif (TPPS) adopt the conformation of a
type II polyproline helix. The N-terminal amino acid (Thr+1)
does not form a direct contact with the EVH1 domain and
indeed, the authors found that position +1 is not conserved
among different Homer interacting proteins. The two amino
acids Pro+3 and Ser+4 also participate in a beta turn that
is formed by the sequence PSPF. As a consequence, the side
chains of the proline residues at position +2 and +3, as well
as of Phe+6 all point to the mGluR/Homer interface and form
direct contacts to the EVH1 domain. In contrast, side chains
of Ser+4 and Pro+5 point away from the binding surface and
are exposed to the solvent. As it is the case for Thr+1, also
these amino acid positions are not conserved in Homer binding
proteins.
MGluR5a/b IN CONTACT WITH TAMALIN
The scaffold protein Tamalin interacts with group I mGluR types
and regulates surface expression and targeting of mGluR1a and
mGluR5a/b in hippocampal neurons (Kitano et al., 2002). The
C-terminal domains of group I mGluRs contact the PDZ-domain
of Tamalin and a peptide representing the very C-terminal amino
acids that are identical between mGluR5a and mGluR5b isoforms
(SSSSL) was used to analyze the geometry of the protein complex
(Sugi et al., 2007). Mostly, PDZ domain binding motifs contain
the C-terminal three amino acids of the ligand, however binding
of PDZ domains to internal protein sequences was also observed
(Lee and Zheng, 2010). While recently up to 16 different classes of
PDZ domains were suggested (Tonikian et al., 2008), traditionally
C-terminally located PDZ domain binding motifs are subdivided
in three classes according to the consensus sequences [ST]x,
x and [DE]x (x—any amino acid; —hydrophobic amino
acid). In these consensus sequences, the amino acid type at posi-
tion −1 is variable, indicating that the side chain of residue −1
does not form specific interactions with the PDZ domain binding
pocket. Therefore, it is interesting that the side chain of Ser−1
of the PDZ domain binding motif SSSSL in the mGluR5 C-
terminus contributes to a hydrogen bonding network in which
a water molecule bridges its hydroxyl group to two polar groups
of Tamalin (Sugi et al., 2007). Thus, amino acids not being part of
consensus sequences for PDZ domain binding motifs can contact
the PDZ domain binding pocket and regulate binding affinities.
Indeed, binding of the mGluR7b C-terminal domain to the PDZ
domains of PICK1 and Syntenin required amino acids located at
positions−6 and−7 of the receptors’ C-terminus (Enz and Croci,
2003).
Without an interaction partner, Tamalin adopts an auto-
inhibited state in which an intrinsic C-terminal sequence
(EESQL) occupies the internal PDZ domain of the scaffold (Sugi
et al., 2007). The mGluR5 C-terminal peptide competes with the
intrinsic ligand of Tamalin for PDZ domain binding. Variations
in electrostatic forces between the two ligands and the PDZ
domain discriminate between interactors. These variations are
due to the above described hydrogen network of Ser−1 and
additional hydrogen bond formation of Ser−3 of the mGluR5
ligand. Both interactions cannot be realized by the intrinsic lig-
and of Tamalin due to its different amino acid sequence. After
binding of the mGluR5 C-terminal PDZ motif, the intrinsic lig-
and of Tamalin is displaced and now able to bind a receptor
for kinesin motor proteins, the synaptic scaffolding molecule
S-SCAM, thereby regulating subcellular trafficking of interact-
ing mGluR types (Kitano et al., 2003). Both binding partners,
mGluR5 and the PDZ domain of Tamalin are able to dimer-
ize, resulting in a tetrameric protein complex (Sugi et al., 2007).
Thus, besides regulating trafficking and surface expression of
group I mGluRs, scaffold proteins might also facilitate receptor
dimerization.
CONCLUSION
Besides the well-known binding of heterotrimeric G-Proteins to
mGluRs, within the last decade a huge diversity of additional
mGluR interactors were identified, the majority of them binding
to the receptors’ intracellular C-termini. While increasing infor-
mation is available describing the conformation of extracellular
and transmembrane domains of G-protein coupled receptors,
structural data elucidating the nature of intracellular receptor
regions is rather sparse. Recently, structural characteristics of
different mGluR C-terminal domains without, or in complex
with binding proteins were reported. From these data a picture
emerges, in which group III mGluR C-termini are intrinsically
disordered and do not seem to form secondary or tertiary struc-
tures that remain stable over time. Rather, these domains adopt
a defined three-dimensional conformation only upon interac-
tion with mGluR binding proteins. MGluR C-termini contain
multiple and sometimes overlapping short linear binding motifs,
most of them clustered in the isoform specific, distal regions of the
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receptor domains. In contrast to preformed folds, the use of short
linear bindingmotifs allows the regulation of the glutamate recep-
tors by a high number of diverse binding partners. In conclusion,
the principle idea that biological functionmay require the absence
of a defined three-dimensional structure is evolving as a gen-
eral feature in living systems and indeed, about 70% of signal
proteins contain intrinsically disordered protein regions (Uversky
and Dunker, 2010).
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